Avidity Partners Management LP - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$42,126,000
-36.0%
2,100,000
-10.0%
1.70%
-26.3%
Q2 2023$65,842,140
+30.7%
2,334,000
-20.3%
2.30%
+37.6%
Q1 2023$50,383,960
-51.4%
2,929,300
-43.1%
1.67%
-25.6%
Q4 2022$103,721,000
+13.4%
5,150,000
+21.9%
2.25%
+20.8%
Q3 2022$91,472,000
-9.2%
4,223,100
+17.8%
1.86%
-19.6%
Q2 2022$100,763,000
-31.3%
3,585,881
+12.9%
2.31%
-24.2%
Q1 2022$146,587,000
-35.8%
3,176,999
+17.0%
3.05%
-36.9%
Q4 2021$228,223,000
+37.3%
2,715,000
+8.9%
4.84%
+31.5%
Q3 2021$166,187,000
+44.6%
2,493,800
+15.5%
3.68%
+18.5%
Q2 2021$114,912,000
+109.6%
2,160,000
+71.0%
3.11%
+105.2%
Q1 2021$54,815,000
-7.0%
1,263,300
+11.3%
1.51%
-20.9%
Q4 2020$58,952,000
+99.5%
1,135,000
+25.5%
1.91%
+39.6%
Q3 2020$29,556,000
-8.7%
904,119
+34.0%
1.37%
-34.0%
Q2 2020$32,389,000674,4872.08%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 300,434$25,254,0007.21%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,628,409$220,944,0006.56%
Avidity Partners Management LP 2,715,000$228,223,0004.84%
Matrix Capital Management Company, LP 4,349,279$365,600,0004.07%
Affinity Asset Advisors, LLC 117,500$9,877,0003.59%
Integral Health Asset Management, LLC 120,000$10,087,0002.79%
Ghost Tree Capital, LLC 80,000$6,725,0002.41%
Ikarian Capital, LLC 191,140$16,067,0002.39%
Tri Locum Partners LP 23,632$1,987,0000.78%
Eventide Asset Management 529,000$44,468,0000.57%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders